AITEM
AiTEM
AITEM is an AI-driven small-molecule formulation design platform developed by METiS Pharmaceuticals (剂泰医药), a Chinese AI-enabled drug-development company . Built on METiS's NanoForge foundation, AITEM sits alongside two sibling platforms—AiLNP and AiRNA—as part of the company's trio of "AI+" core technology solutions . The platform was already in METiS's self-developed pipeline as of mid-2024 and remained a featured technology at the company's May 2026 Hong Kong IPO .
AI-generated — may contain errors, please verify.
Coverage
5Y News | Congratulations to METiS Pharmaceuticals on its Hong Kong Stock Exchange listing!
METiS Pharmaceuticals, the world's first publicly listed AI-driven drug delivery company, goes public, ushering in a new era for biopharmaceuticals.
Heart Capital Congratulates METiS Pharmaceuticals on Successful Listing on the Main Board of the Hong Kong Stock Exchange | Heart Star PORTFOLIO
The world's first publicly listed AI drug delivery company.
5Y News | 5Y Capital Portfolio Company METiS Pharmaceuticals Closes $100 Million Series C Round
Focused on "AI-powered drug delivery."
